Market Cap

Genscript Biotech Corp Market Capitalization:

$3.21 Billion

USD as of July 1, 2024

business Genscript Biotech Corp Company Profile

Genscript Biotech Corp Main Stock Listing

OTC: GNNSF

Market Capitalization History of Genscript Biotech Corp

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Genscript Biotech Corp market cap

Date Market Cap YoY Change
Jan. 1, 2024 $5.18 B -27.95%
Jan. 1, 2023 $7.19 B -3.79%
Jan. 1, 2022 $7.47 B 132.95%
Jan. 1, 2021 $3.21 B -42.61%
Jan. 1, 2020 $5.59 B 55.41%
Jan. 1, 2019 $3.60 B -56.47%
Jan. 1, 2018 $8.26 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Genscript Biotech Corp Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Genscript Biotech Corp has the following listings and related stock indices.


Stock: OTC: GNNSF

Stock: FSX: G51

Stock: HKEX: 1548

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.